Erik Anders Kronström
Chief Operating Officer presso INFANT BACTERIAL THERAPEUTICS AB
Patrimonio netto: 89 953 $ in data 30/04/2024
Posizioni attive di Erik Anders Kronström
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Chief Operating Officer | 01/01/2018 | - |
| Chief Tech/Sci/R&D Officer | 20/10/2014 | 01/01/2018 |
Storia della carriera di Erik Anders Kronström
Precedenti posizioni note di Erik Anders Kronström
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Chief Executive Officer | - | - |
Formazione di Erik Anders Kronström
| Warwick Business School | Masters Business Admin |
| Royal Institute of Technology | Graduate Degree |
Statistiche
Distribuzione geografica
| Svezia | 3 |
| Regno Unito | 2 |
| Norvegia | 2 |
Posizioni
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
| Masters Business Admin | 1 |
Settori
| Consumer Services | 3 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Health Technology |
| Aziende private | 1 |
|---|---|
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
